| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/01/2006 | WO2006056885A2 Igf-1 isoforms |
| 06/01/2006 | WO2006056825A1 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 06/01/2006 | WO2006056733A1 Gamma-delta t cell receptors |
| 06/01/2006 | WO2006056623A1 Ccr6-deficient mice or cells and modulation of inflammatory diseases |
| 06/01/2006 | WO2006056575A1 Purification of recombinant human factor xiii |
| 06/01/2006 | WO2006056492A1 Therapeutic peptides comprising sequences derived from cdr2 or cdr3 of trem-1 and uses thereof to inhibit sepsis |
| 06/01/2006 | WO2006056484A1 Protein isolation and purification |
| 06/01/2006 | WO2006056483A1 Production of proteins |
| 06/01/2006 | WO2006056479A1 Sly1 inhibitors in transplantation |
| 06/01/2006 | WO2006056370A1 Fusion protein comprising a bh3-domain of a bh3-only protein |
| 06/01/2006 | WO2006056259A1 Treatment of neurodegenerative diseases by the use of laptm4a |
| 06/01/2006 | WO2006056027A1 Human cytomegalovirus immunotherapy |
| 06/01/2006 | WO2006029487A3 Platelet factor 4 variant 1 (pf4var1) related inhibitors of angiogenesis |
| 06/01/2006 | WO2006024547A3 Protease resistant human and non-human hmgb1 box-a mutants and their therapeutic/diagnostic use |
| 06/01/2006 | WO2006014493A3 Mechanically activated channel blocker |
| 06/01/2006 | WO2006014468A3 Saif, an anti-inflammatory factor, and methods of use thereof |
| 06/01/2006 | WO2006012092A3 Safer attenuated virus vaccines with missing or diminished latency of infection |
| 06/01/2006 | WO2006010106A3 Dna-based vaccination of retroviral-infected individuals undergoing treatment |
| 06/01/2006 | WO2006005975A3 Homo and heterodimer proteins of the abcg family, methods for detection and screening modulators thereof |
| 06/01/2006 | WO2006005825A3 Novel polypeptides for isolating in vitro and preventing staphyloccocal infections on joint prostheses and other implanted foreign materials |
| 06/01/2006 | WO2005123958A3 Cd7 as biomarker and therapeutic target for psoriasis |
| 06/01/2006 | WO2005123766A3 Methods of making nanotechnological and macromolecular biomimetic structures |
| 06/01/2006 | WO2005117975A3 Methods for treating vascular disease |
| 06/01/2006 | WO2005113598A3 Tnf super family members with altered immunogenicity |
| 06/01/2006 | WO2005113595A3 High affinity ny-eso t cell receptor |
| 06/01/2006 | WO2005112968A3 Method of using recombinant human antithrombin for neurocognitive disorders |
| 06/01/2006 | WO2005111216A3 Methods for modifying plant characteristics |
| 06/01/2006 | WO2005101993A9 Metal-containing nanolayered composites, and applications thereof |
| 06/01/2006 | WO2005100395A3 EXPRESSION SYSTEM FOR PREPARING IL-15/Fc FUSION PROTEINS AND ITS USE |
| 06/01/2006 | WO2005094356A3 Cngh0011 polynucleotides, polypeptides, antibodies, and compositions, and methods of production and use |
| 06/01/2006 | WO2005076786A3 Colon carcinoma related oligonucleotides and methods of use |
| 06/01/2006 | WO2005063299A3 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 06/01/2006 | WO2005049642A3 Genome of legionella pneumophila paris and lens strain-diagnostic and epidemiological applications |
| 06/01/2006 | WO2005047478A3 Compositions and methods for regulation of tumor necrosis factor-alpha |
| 06/01/2006 | WO2005017123A3 Mptens as modifiers of the pten pathway and methods of use |
| 06/01/2006 | WO2005012492A8 Human skin equivalents expressing exogenous polypeptides |
| 06/01/2006 | WO2005001025A3 Immunoglobulin chimeric monomer-dimer hybrids |
| 06/01/2006 | WO2004099386A3 Gene silencing by systemic rna interference |
| 06/01/2006 | WO2004085617B1 TIMP3 as VEGF inhibitor |
| 06/01/2006 | WO2004004656A3 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
| 06/01/2006 | WO2003025542A3 Immune response associated proteins |
| 06/01/2006 | US20060117412 Stable plastid transformation and expression vector for transferring target nucleotide sequences into plants for mass production of affordable vaccines and pharmaceutical agents |
| 06/01/2006 | US20060117410 Locked nucleic acid containing heteropolymers and related methods |
| 06/01/2006 | US20060117407 Method of producing transgenic maize using direct transformation of commercially important genotypes |
| 06/01/2006 | US20060116508 Novel 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC 1C, NARC 1A, NARC 25, 86604 and 32222 molecules and uses therefor |
| 06/01/2006 | US20060116507 Osteogenic devices |
| 06/01/2006 | US20060116506 Tenebrio antifreeze proteins |
| 06/01/2006 | US20060116505 Glucose and/or fructose transporter naglt1 and its gene |
| 06/01/2006 | US20060116504 polypeptides used as biomarkers for the analysis and medical prognosis of liver disorders associated with alcoholism |
| 06/01/2006 | US20060116341 Pharmaceutical composition for treating and/or preventing a pathology associated with an obsessional behavior or with obesity |
| 06/01/2006 | US20060116338 Therapeutic and diagnostic tools for proliferative and developmental disorders and as vehicles for identifying region q26.2 on a mammalian chromosome 3; gene therapy; detecting Cornelia de Lange syndrome; diagnosing neoplasia; inducing a cell to change its pattern of differentiation |
| 06/01/2006 | US20060116325 Methods and compositions for inhibiting hiv-coreceptor interactions |
| 06/01/2006 | US20060116323 Tumor-inhibiting protein and the use thereof |
| 06/01/2006 | US20060116322 Formation of novel erythropoietin conjugates using transglutaminase |
| 06/01/2006 | US20060116320 Growth hormone crystals and a process for production of these GH-crystals |
| 06/01/2006 | US20060116317 Dyeing keratin material; using ninhydrin material |
| 06/01/2006 | US20060116315 Method of screening agent for improving memory and learning ability |
| 06/01/2006 | US20060115897 Compositions and methods modulating variola and vaccinia virus |
| 06/01/2006 | US20060115876 Antihemophilic factor (FVIII) muteins covalently bound to biocompatabile polyoxyethylene glycol; low-density lipoprotein receptor; pharmacokinetics; chromatography; hemophilia |
| 06/01/2006 | US20060115874 Enrichment method for variant proteins with altered binding properties |
| 06/01/2006 | US20060115867 TRIM 5 related protein as a biomarker of neurodegenerative disease |
| 06/01/2006 | US20060115865 Lamotrigine analogs |
| 06/01/2006 | US20060115859 Tyrosylprotein sulfotransferases and methods of use thereof |
| 06/01/2006 | US20060115858 Trace amine 1 receptor of the African green monkey |
| 06/01/2006 | US20060115855 FK506-binding protein 7 related protein as a biomarker for neurodegenerative disease |
| 06/01/2006 | US20060115854 Acetyl-LDL receptor related proteins and peptides as a biomarker for neurodegenerative disease |
| 06/01/2006 | US20060115853 Polynucleotides, polypeptides and method for screening for useful dog candidates |
| 06/01/2006 | US20060115852 proteins or polypeptides comprising amino acid sequences, used for diagnosis and therapy of diseases associated with oncogenes, such as transcription and apoptosis |
| 06/01/2006 | US20060115848 Nucleic acid end-labeling reagents |
| 06/01/2006 | US20060115847 immunological TB diagnostic tool based on a combination of epitopes from proteins encoded by regions of the M. tuberculosis genome that are not present in the BCG vaccine strain or in the most common non-tuberculosis mycobacteria |
| 06/01/2006 | US20060115831 Map |
| 06/01/2006 | US20060115825 PNA chip using zip-codes and fabrication method thereof |
| 06/01/2006 | US20060115820 Primer and probe for detecting vibrio cholerae or vibrio mimicus and detection method using the same |
| 06/01/2006 | US20060115817 Span-xb gene and protein for the diagnosis and treatment of cancer |
| 06/01/2006 | US20060115816 Splice variant cannabinoid receptor (cb1b) |
| 06/01/2006 | US20060115813 Intracellular signaling molecules |
| 06/01/2006 | US20060115498 DNA encoding an antigenic protein of Eimeria apical membrane antigen 1 and use thereof |
| 06/01/2006 | US20060115497 Mycobacterium strains with modified erp gene and vaccine composition containing same |
| 06/01/2006 | US20060115496 Toxoplasma gondii proteins, nucleic acid molecules, and uses thereof |
| 06/01/2006 | US20060115491 Vaccine delivery; attaching immunogenic determinant of heterologous polypeptide biodrug to the peptidoglycan microparticle on cell wall of a Gram-positive bacterium; improve the binding by treating the cell wall with acid solution to remove protein, lipotechoic, carbohydrates |
| 06/01/2006 | US20060115490 vaccines, immunogenic compositions; diagnostics, enzymatic studies and targets for antibiotics; for treating Staphylococcus aureus infection |
| 06/01/2006 | US20060115489 Influenza immunogen and vaccine |
| 06/01/2006 | US20060115488 Identification of new CD8 epitopes from HIV-1 proteins with therapeutical and vaccinal properties against HIV infections |
| 06/01/2006 | US20060115484 Nucleic acid for modulating apoptosis |
| 06/01/2006 | US20060115483 Receptor polypeptide and polynucleotide encoding polypeptide; anticancer agents; viricides; multiple sclerosis; antiarthritic agents; cardiovascular disorders; osteoporosis |
| 06/01/2006 | US20060115479 Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof |
| 06/01/2006 | US20060115477 Neuropilin-1 inhibitors |
| 06/01/2006 | US20060115464 Use of cardiotrophin to modulate stem cell proliferation |
| 06/01/2006 | US20060115451 Modified cytokines for use in cancer therapy |
| 06/01/2006 | DE19910102B4 Proteinkonjugate, Verfahren, Vektoren, Proteine und DNA zu deren Herstellung, deren Verwendung, sowie Arzneimittel und Impfstoffe mit einem Gehalt derselben Protein conjugates, methods, vectors, proteins, and DNA for their preparation, their use, as well as drugs and vaccines containing the same |
| 06/01/2006 | DE102004058893A1 New modified biopolymer (obtained by reacting a bio polymer with glucuronic acid) useful e.g. for the induction or promotion of the biomineralization and the production of biomaterial; and as bone replacement material |
| 06/01/2006 | CA2590512A1 Fusion protein comprising a bh3-domain of a bh3-only protein |
| 06/01/2006 | CA2589561A1 Treatment of neurodegenerative diseases by the use of laptm4a |
| 06/01/2006 | CA2589487A1 Means and methods for detecting methylated dna |
| 06/01/2006 | CA2589471A1 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (pth) 1-84 |
| 06/01/2006 | CA2589460A1 New peptides useful as dual caspase-2/-6 inhibitors and their biological applications |
| 06/01/2006 | CA2589164A1 Production of proteins |
| 06/01/2006 | CA2589158A1 Protein isolation and purification |
| 06/01/2006 | CA2588464A1 Plant transformed with a nucleic acid encoding an osmads18-like polypeptide having increased yield and methods for making the same |
| 06/01/2006 | CA2587643A1 Method for designing polypeptides for the nanofabrication of thin films, coatings, and microcapsules by electrostatic layer-by-layer self assembly |